CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-27 | Henderson Mary Elizabeth SVP, Technical Operations | Grant or award | +3,852 | 23,775 | ||
| 2025-02-27 | Pearce Samantha EVP, Chief Commercial Officer | Grant or award | +11,941 | 37,353 | ||
| 2025-02-27 | Pearce Samantha EVP, Chief Commercial Officer | Grant or award | +5,778 | 43,131 | ||
| 2025-02-27 | GALA RENEE D President & COO | Grant or award | +23,111 | 83,044 | ||
| 2025-02-27 | GALA RENEE D President & COO | Grant or award | +11,555 | 94,599 | ||
| 2025-02-27 | Johnson Philip L EVP & Chief Financial Officer | Grant or award | +15,407 | 43,505 | ||
| 2025-02-27 | Johnson Philip L EVP & Chief Financial Officer | Grant or award | +7,704 | 51,209 | ||
| 2025-02-27 | Carr Patricia SVP, Chief Accounting Officer | Option exercise | +4,500 | $113.10 | $509K | 12,737 |
| 2025-02-27 | Carr Patricia SVP, Chief Accounting Officer | Sale | −4,500 | $144.42 | $650K | 8,237 |
| 2025-02-27 | Carr Patricia SVP, Chief Accounting Officer | Option exercise | +313 | $123.36 | $39K | 8,550 |
| 2025-02-27 | Carr Patricia SVP, Chief Accounting Officer | Sale | −313 | $144.42 | $45K | 8,237 |
| 2025-02-27 | Carr Patricia SVP, Chief Accounting Officer | Returned to the company | −371 | $142.43 | $53K | 7,866 |
| 2025-02-27 | Carr Patricia SVP, Chief Accounting Officer | Returned to the company | −497 | $142.43 | $71K | 7,369 |
| 2025-02-27 | Carr Patricia SVP, Chief Accounting Officer | Grant or award | +2,889 | 10,258 | ||
| 2025-02-27 | Carr Patricia SVP, Chief Accounting Officer | Option exercise · Non-Qualified Stock Option (right to buy) | −4,500 | 0 | ||
| 2025-02-27 | Carr Patricia SVP, Chief Accounting Officer | Option exercise · Non-Qualified Stock Option (right to buy) | −313 | 0 | ||
| 2025-02-27 | Patil Neena M EVP & Chief Legal Officer | Sale | −3,800 | $144.87 | $551K | 33,318 |
| 2025-02-27 | Patil Neena M EVP & Chief Legal Officer | Grant or award | +12,518 | 45,836 | ||
| 2025-02-27 | Patil Neena M EVP & Chief Legal Officer | Grant or award | +5,778 | 51,614 | ||
| 2025-02-27 | COZADD BRUCE C Chairman & CEO | Grant or award 10b5-1 | +30,814 | 470,558 |
Page 13 of 31 · 614 trades